Biolife Solutions Inc (NASDAQ:BLFS)’s traded shares stood at 0.82 million during the last session, with the company’s beta value hitting 1.83. At the close of trading, the stock’s price was $22.03, to imply a decrease of -5.45% or -$1.27 in intraday trading. The BLFS share’s 52-week high remains $29.55, putting it -34.14% down since that peak but still an impressive 15.12% since price per share fell to its 52-week low of $18.70.
Analysts have given a consensus recommendation of Buy for Biolife Solutions Inc (BLFS), translating to a mean rating of 1.00. Of 4 analyst(s) looking at the stock, 0 analyst(s) give BLFS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.01.
Biolife Solutions Inc (NASDAQ:BLFS) trade information
After registering a -5.45% downside in the last session, Biolife Solutions Inc (BLFS) has traded red over the past five days. The 5-day price performance for the stock is -7.09%, and -0.09% over 30 days. With these gigs, the year-to-date price performance is -15.14%.
The extremes give us $30 and $30 for target low and target high price respectively. As such, BLFS has been trading -36.18% off suggested target high and -36.18% from its likely low.
Biolife Solutions Inc (BLFS) estimates and forecasts
The rating firms project that company’s revenue will grow 18.84% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is 23.71M. Meanwhile, for the current quarter, a total of 9 analyst(s) estimate revenue growth to 24.56M.Earnings reports from the last fiscal year show that sales brought in 28.33M and 30.57M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -16.30% before dropping -19.66% in the following quarter.
BLFS Dividends
Biolife Solutions Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is BLACKROCK INC. with 5.49 million shares, or about 11.9296% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $117.61 million.
We also have iShares Trust-iShares Core S&P Small-Cap ETF and ALGER FUNDS-Alger Small Cap Focus Fund as the top two Mutual Funds with the largest holdings of the Biolife Solutions Inc (BLFS) shares. Going by data provided on Apr 30, 2025 , iShares Trust-iShares Core S&P Small-Cap ETF holds roughly 2.19 shares. This is just over 4.61% of the total shares, with a market valuation of $48.2 million. Data from the same date shows that the other fund manager holds a little less at 1.41, or 2.98% of the shares, all valued at about 31.17 million.
